Fri, Aug 1, 2014, 4:12 AM EDT - U.S. Markets open in 5 hrs 18 mins

Recent

% | $
Click the to save as a favorite.

Cytosorbents Corporation Message Board

  • dr_lowenstein dr_lowenstein Mar 18, 2012 1:32 PM Flag

    hmmmmmmm

    Curr Opin Infect Dis. 2012 Mar 14. [Epub ahead of print]
    Predictors of survival in sepsis: what is the best inflammatory marker to measure?
    Lichtenstern C, Brenner T, Bardenheuer HJ, Weigand MA.
    Source

    aDepartment of Anesthesiology and Intensive Care Medicine, University Hospital of Giessen and Marburg, Giessen bDepartment for Anesthesiology, University Hospital of Heidelberg, Heidelberg, Germany.
    Abstract
    PURPOSE OF REVIEW:

    Sepsis is relevant due to its high morbidity and mortality. For both sepsis diagnosis and outcome prediction many biomarkers have been described in the literature. Most of these markers are objects of scientific interest rather than being introduced into daily clinical practice. However, due to their unspecific character and their insufficient predictive value for the individual person, research focus is still on new aspects in sepsis-related biomarkers.
    RECENT FINDINGS:

    Beyond the widely used acute-phase proteins C-reactive protein (CRP) and procalcitonin (PCT), many new molecules have been studied deriving from different organs or cells affected, due to the systemic nature of sepsis. Cytokines, coagulation factors/characteristics, vasoactive hormones, and several others have been recently proved to be relevant in sepsis syndrome and probably useful for outcome prediction. However, single time point measurements may be less predictive than consideration of the time-dependent course of parameters. Clinical decision just based on a biomarker is still not feasible because of the huge inter-individual differences in the inflammatory response.
    SUMMARY:

    Many biomarkers display relevant correlation with the clinical outcome of patients with severe sepsis and septic shock. Consideration of their time courses may be more reliable than absolute levels. Clinical decision should not be based only on biomarkers but organ dysfunctions, for example, should also be taken into account.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
CTSO
0.241-0.004(-1.63%)Jul 31 3:39 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Tesla Motors, Inc.
NasdaqGSThu, Jul 31, 2014 4:00 PM EDT
eHealth, Inc.
NasdaqGSThu, Jul 31, 2014 3:59 PM EDT